A recent study used deep learning (DL) to reduce batch effects in Raman spectroscopy data from glioma samples, retaining 81% balanced accuracy for IDH1 mutation classification while lowering patient-identification balanced accuracy from 68% to 12%, according to findings published in Scientific Reports. Raman spectroscopy is a non-destructive technique that uses laser light to identify chemical components of biological tissue, and combining it with AI has improved its use in medical diagnosis, including identifying brain tumors during surgery. However, the technique is sensitive to variations in laser power, room lighting, instrument settings, sample handling, and background fluorescence—known as batch effects—which can cause AI models to learn differences in measurement conditions rather than disease-related signals. Researchers analyzed the APOLLO glioma cohort, containing 300,506 Raman spectra from 59 tumor specimens across 46 patients, collected using a Raman microscope with a 532 nm laser, a 10× air objective, and an electron-multiplied charge-coupled device detector recording spectra across 50–3400 cm-1. After quality-control filters based on intensity quantiles, 260,922 spectra were retained. The study compared raw spectra, spectra denoised and baseline-corrected using the RADAR method, and manually baseline-corrected spectra, each normalized using min-max scaling. A DL framework combining a learnable feature-importance layer with one-dimensional convolutional neural networks was developed to reduce patient-specific bias.